Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1275 of 2873 entries
View as:

F18 Fluciclovine PET/CT in Assessing Tumor Volume and Radiation Therapy Response in Patients With Glioblastoma Undergoing Surgery

Phase: N/A Priority: Normal
NCT ID: NCT03926507 Org: User:
Start: 04/30/19 End: 09/18/23 Due: 09/18/24

Effects of Vitamin D Replacement in Patients With Primary Hyperparathyroidism (PHPT)

Phase: N/A Priority: Normal
NCT ID: NCT00538720 Org: User:
Start: 10/31/07 End: 05/30/18 Due: 05/30/19

Randomized Trial of Glutamine in Patients With Mucositis or Esophagitis

Phase: N/A Priority: Normal
NCT ID: NCT01952847 Org: User:
Start: 07/10/14 End: 03/03/21 Due: 03/03/22

Phase 2 Trial of Neoadjuvant and Adjuvant Tiragolumab Plus Atezolizumab in Patients With Newly Diagnosed PD-L1 CPS Positive Resectable Stage 3-4 Oral Cavity Squamous Cell Carcinoma (OCSCC).

Phase: N/A Priority: Normal
NCT ID: NCT05681039 Org: User:
Start: 06/02/23 End: 11/01/26 Due: 11/01/27

Photopheresis for the Treatment of Acute Graft Versus Host Disease

Phase: N/A Priority: Normal
NCT ID: NCT00609609 Org: User:
Start: 01/31/08 End: 01/31/16 Due: 01/31/17

An Early Stress-Reduction Intervention in Patients With Newly Diagnosed Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03429907 Org: User:
Start: 12/05/17 End: 04/30/26 Due: 04/30/27

Decision Aid Website in Helping to Make Decisions About Fertility in Participants With Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03141437 Org: User:
Start: 04/23/17 End: 04/30/27 Due: 04/30/28

Couple-Based Meditation for Metastatic Lung Cancer Patients and Their Partners

Phase: N/A Priority: Normal
NCT ID: NCT02596490 Org: User:
Start: 04/06/16 End: 12/01/26 Due: 12/01/27

T-Cell Responses to Neoantigens Post Treatment With Ipilimumab in Men With Metastatic Castration-Resistant Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02113657 Org: User:
Start: 08/20/14 End: 11/04/19 Due: 11/04/20

Observational Prospective Research Study In Monoclonal Gammopathies leadINg to Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT02726750 Org: User:
Start: 12/14/15 End: 04/30/26 Due: 04/30/27

Phase 1 Dose Escalation and Dose Expansion Trial of NP-101 in Patients With Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT06563375 Org: User:
Start: 03/05/25 End: 09/01/30 Due: 09/01/31

Carfilzomib, Bendamustine Hydrochloride, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT02095834 Org: User:
Start: 04/24/14 End: 01/07/21 Due: 01/07/22

An Evidence-Based Focal Cryotherapy Protocol for Focal Ablation of Intermediate Risk Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05454488 Org: User:
Start: 07/25/22 End: 01/31/26 Due: 01/31/27

Study of Temsirolimus, Topotecan, and Bortezomib

Phase: N/A Priority: Normal
NCT ID: NCT00770731 Org: User:
Start: 09/30/08 End: 11/30/12 Due: 11/30/13

Lenalidomide for Patients With Myelofibrosis (MF)

Phase: N/A Priority: Normal
NCT ID: NCT00352794 Org: User:
Start: 07/07/06 End: 03/08/18 Due: 03/08/19

Proteasome Inhibitor PS-341 Relapsed or Refractory B Cell Lymphomas Previously Treated With Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT00038571 Org: User:
Start: 05/31/02 End: 03/31/05 Due: 03/31/06

Message: Study of Patients' Perception of Physician's Compassion

Phase: N/A Priority: Normal
NCT ID: NCT02357108 Org: User:
Start: 05/31/13 End: 08/31/15 Due: 08/31/16

Low-Dose Decitabine in Myelodysplastic Syndrome Post Azacytidine Failure

Phase: N/A Priority: Normal
NCT ID: NCT00113321 Org: User:
Start: 03/31/05 End: 11/30/08 Due: 11/30/09

Methylprednisolone, Horse Anti-Thymocyte Globulin, Cyclosporine, Filgrastim, and/or Pegfilgrastim or Pegfilgrastim Biosimilar in Treating Patients With Aplastic Anemia or Low or Intermediate-Risk Myelodysplastic Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT01624805 Org: User:
Start: 06/25/12 End: 06/30/26 Due: 06/30/27

Nurse-Driven Telephone Intervention in Improving Side Effects in Cancer Patients Undergoing Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT03964896 Org: User:
Start: 10/17/16 End: 12/18/19 Due: 12/18/20

Zoledronate With Atorvastatin in Renal Cell Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT00490698 Org: User:
Start: 10/31/06 End: 01/31/12 Due: 01/31/13

External Beam Radiation Therapy (EBRT) With or Without Hormonal Therapy in Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00388804 Org: User:
Start: 02/28/05 End: 04/30/11 Due: 04/30/12

Biobehavioral Effects of Emotional Expression in Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00505310 Org: User:
Start: 08/21/02 End: 08/10/22 Due: 08/10/23

Doxorubicin and Strontium-89 With or Without Celecoxib in Treating Patients With Progressive Androgen-Independent Prostate Cancer and Bone Metastases

Phase: N/A Priority: Normal
NCT ID: NCT00080782 Org: User:
Start: 02/28/02 End: 01/31/05 Due: 01/31/06

Surgery Versus Stereotactic Radiosurgery in the Treatment of Single Brain Metastasis: A Randomized Trial

Phase: N/A Priority: Normal
NCT ID: NCT00460395 Org: User:
Start: 01/31/98 End: 12/31/05 Due: 12/31/06